Please wait...

Learn

Finding accredited CPD

Axicabtagene Ciloleucel for Second-Line Treatment of Relapsed or Refractory Large B-Cell Lymphoma

Description

A series of videos presented by Professor Michael Dickinson discussing CAR T-Cell Therapy: Axicabtagene Ciloleucel for Second-Line Treatment of Relapsed or Refractory Large B-Cell Lymphoma.

In this video, Professor Dickinson presents on the Role of Axi-cel in second-line treatment, eligibility criteria, choosing second-line Axi-cel and safety data.

 

 

 


Details

Presented by Professor Michael Dickinson MBBS, D Med Sc, FRACP, FRCPA.

This activity is accepted by CPD Home as a Domain 1: Educational Activity in alignment with the CPD Home Program Guide.

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website. 

CPD Activity Details
Provider
Domain
Educational Activities
Type
General Learning
Activity
Webinar
CPD Hours
0h : 15m
Topic
Oncology, Haematologic Diseases
Audience
Medical practitioners
Applicable CAPE Aspects
_
Effective Year

You have to log in to see the content of this module.


Provided by


Accepted by